A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
Clinical trial NCT05567952 · COMPLETED
Trial details
- NCT number
- NCT05567952
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-19
- Primary completion
- 2023-09-27
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.